This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Other. Active years: 2014.
Company Filing History:
1 out of 834,307 Years Active: 2014
Title: Eeva Jokela: Innovator in Vaccine Development
Introduction
Eeva Jokela is a notable inventor based in Tampere, Finland. She has made significant contributions to the field of vaccine development, particularly in the area of norovirus and rotavirus prevention. Her innovative work has the potential to impact public health positively.
Latest Patents
Eeva Jokela holds a patent for a combined norovirus and rotavirus vaccine. The patent, titled "Norovirus capsid and rotavirus VP6 protein for use as combined vaccine," focuses on preventing norovirus and rotavirus infections, as well as viral-induced diarrheal and vomiting diseases in humans. The invention details a method for preparing combination vaccine compositions that include norovirus and rotavirus antigens, specifically mixtures of norovirus virus-like particles (VLPs) and rotavirus recombinant VP6 protein or double-layered VP2/VP6 VLPs. Additionally, the invention outlines methods for inducing an immune response.
Career Highlights
Throughout her career, Eeva Jokela has been involved in groundbreaking research and development in the field of immunology. Her work has led to advancements in vaccine technology, particularly in addressing viral infections that pose significant health risks.
Collaborations
Eeva has collaborated with notable professionals in her field, including Timo Vesikari and Vesna Blazevic. These collaborations have contributed to the success of her research and the development of her patented vaccine.
Conclusion
Eeva Jokela's contributions to vaccine development highlight her role as an innovator in the field. Her patent for a combined norovirus and rotavirus vaccine represents a significant advancement in public health.